2030년까지 북미 골관절염 치료 시장 예측 - 지역 분석 - 치료 유형별(경피 전기 신경 자극(TENS), 작업 치료, 물리 치료, 혈소판 풍부 플라즈마 치료 및 기질 혈관 분획, 프롤로 치료 및 기타), 질병 적응증(무릎) 골관절염, 척추 골관절염, 발 및 발목 골관절염, 어깨 골관절염, 손 골관절염 등) 및 최종 사용자(병원 및 진료소, 전문 진료소, 외래 수술 센터, 홈케어 등)
더 효과적인 치료 옵션이 북미 골관절염 치료 시장에 연료를 공급합니다.
현재 OA에 대한 치료법은 없습니다. 임상연구 과학자 그룹은 임상시험을 통해 골관절염의 진행을 멈출 수 있는 혁신적인 치료 목표 옵션을 개발하고 있음을 밝혔습니다. 일례로 2021년 11월 LG화학은 관절염 치료를 위한 차세대 신약 임상시험 개시를 발표했다. 또한 2021년 10월 Pacira BioSciences, Inc.는 비마약성 통증 관리 \"ZILRETTA\"를 치료하기 위한 Flexion Therapeutics 인수를 발표했습니다. 2017년에 승인된 약물은 서방형 마이크로스피어 기술을 활용한 최초이자 유일한 OA 무릎 통증 치료제입니다.
2023년 9월, Sorrento Therapeutics, Inc.는 \"Resinifera톡신(RTX) 프로그램\"에 대한 긍정적인 2상 최상위 임상 시험 결과를 발표했습니다. 2상 시험은 중등도에서 중증의 OAK 환자의 통증을 관리하기 위해 RTX의 여러 용량 그룹의 효능과 안전성을 평가하는 다기관, 이중 맹검, 위약 및 능동 대조 연구입니다. 또한 소렌토는 현재 승인된 경쟁 약물인 \'질레타\'를 현재 임상시험 프로토콜에 포함하기로 결정했다.
북미 골관절염 치료 시장 개요
북미 골관절염 치료 시장은 미국, 캐나다 및 멕시코로 분류됩니다. 골관절염 치료제에 대한 미국 식품의약국(FDA)의 빠른 제품 출시와 제품 출시 가속화를 위한 정부 지원이 시장 성장에 가장 큰 영향을 미치는 요인입니다. 질병 통제 예방 센터(CDC) 보고서에서 밝혀진 통계에 따르면 골관절염(OA)은 관절염의 가장 흔한 형태로 미국 성인 3,250만 명에게 영향을 미칩니다. 또한 골관절염(OA) Action Alliance 보고서에 따르면 미국에서 골관절염과 관련된 전반적인 경제적 부담은 연간 1,368억 달러로 추산됩니다. 또한 미국 Roentgen Ray Society ARRS 보고서에 따르면 골관절염의 평생 위험은 50%이며, 2040년까지 약 7,800만 명(26%)의 미국 성인이 골관절염을 앓게 될 것으로 추정됩니다.
또한, OA 통증에 대한 비약물적 치료법을 목표로 하는 제조업체의 신제품 승인은 시장 성장에 더욱 영향을 미칩니다. 예를 들어, 2021년 6월 CyMedica Orthopedics는 미국 식품의약국(USFDA)으로부터 무릎 골관절염 통증에 대한 비침습적 방식인 \"Intellihab 시스템\"에 대한 승인을 받았다고 발표했습니다. 신제품 출시는 쇠약해지는 골관절염 질환과 함께 골관절염 통증을 치료하도록 설계된 치료 및 디지털 기반 생태계입니다. 따라서, 치료제에 대한 의존도를 줄이는 데 초점을 맞춘 골관절염 통증을 위한 새로운 비약리학적 치료법은 골관절염 치료 시장의 성장을 촉진하는 핵심 요소입니다.
2030년까지 북미 골관절염 치료 시장 수익 및 예측(미화 백만 달러)
북미 골관절염 치료 시장 세분화
북미 골관절염 치료 시장은 치료 유형으로 분류됩니다. , 질병 적응증, 최종 사용자 및 국가.
북미 골관절염 치료 시장은 치료 유형에 따라 경피 전기 신경 자극(TENS), 작업 치료, 물리 치료, 혈소판 풍부 혈장(PRP) 치료 및 간질 혈관 분획, 증식 치료, 다른 사람. 물리 치료 부문은 2022년 가장 큰 시장 점유율을 차지했습니다.
질병 적응증 측면에서 북미 골관절염 치료 시장은 무릎 골관절염, 척추 골관절염, 발 및 발목 골관절염, 어깨 골관절염, 손 골관절염, 다른 사람. 무릎 골관절염 부문은 2022년 북미 골관절염 치료 시장에서 가장 큰 점유율을 차지했습니다.
최종 사용자를 기준으로 북미 골관절염 치료 시장은 병원 및 진료소, 전문 진료소, 외래 수술 센터, 홈케어, 다른 사람. 홈케어 부문은 2022년 북미 골관절염 치료제 시장에서 가장 큰 점유율을 차지했습니다.
국가별로 북미 골관절염 치료제 시장은 미국, 캐나다, 멕시코로 분류됩니다. 미국은 2022년 북미 골관절염 치료 시장 점유율을 장악했습니다.
Vision Quest Industries Inc, Dr PRP USA LLC, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc 및 Medi GmbH & Co KG는 북미 골관절염 치료 시장에서 활동하는 선도적인 회사 중 일부입니다.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Osteoarthritis Therapy Market Landscape
4.1 Pipeline Analysis
4.1.1 Clinical Trial Pipeline Analysis
5. North America Osteoarthritis Therapy Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Osteoarthritis
5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
5.2.1 Product Recall
5.3 Market Opportunities
5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:
6. Osteoarthritis Therapy Market - North America Market Analysis
6.1 Overview
6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
7. North America Osteoarthritis Therapy Market Analysis - by Therapy Type
7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
7.2.1 Overview
7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
7.3.1 Overview
7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
7.4.1 Overview
7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
7.5.1 Overview
7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
7.6.1 Overview
7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Osteoarthritis Therapy Market Analysis - by Disease Indication
8.1 Overview
8.2 Knee Osteoarthritis
8.2.1 Overview
8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
8.3.1 Overview
8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
8.4.1 Overview
8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
8.5.1 Overview
8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
8.6.1 Overview
8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Osteoarthritis Therapy Market Analysis - by End User
9.1 Overview
9.2 Hospitals and Clinics
9.2.1 Overview
9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
9.3.1 Overview
9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
9.5.1 Overview
9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10. North America Osteoarthritis Therapy Market - Country Analysis
10.1 North America Market Overview
10.1.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
10.1.1.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
10.1.1.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
10.1.1.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
10.1.1.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Vision Quest Industries Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Dr PRP USA LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Zimmer Biomet Holdings Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 DePuy Synthes Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Bioventus Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Omron Healthcare Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Exactech Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Medi GmbH & Co KG
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Insight Partners
List of Tables
Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Organic Developments Done by Companies
Table 13. Inorganic Developments Done by Companies
List of Figures
Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Osteoarthritis Therapy Market by Key Countries - Revenue (2022) US$ Million
Figure 26. North America: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Osteoarthritis Therapy market
1. Vision Quest Industries Inc
2. Dr PRP USA LLC
3. Zimmer Biomet Holdings Inc
4. DePuy Synthes Inc
5. Bioventus Inc
6. Omron Healthcare Inc
7. Exactech Inc
8. Medi GmbH & Co KG
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America osteoarthritis therapy market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America osteoarthritis therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America osteoarthritis therapy market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.